Last edited by Mogar
Wednesday, May 13, 2020 | History

2 edition of Somatostatin analogs in cancer management found in the catalog.

Somatostatin analogs in cancer management

by Carmelo Scarpignato

  • 386 Want to read
  • 11 Currently reading

Published by Karger in Basel, Freiburg, Paris [etc.] .
Written in English

    Subjects:
  • Physiopathologie,
  • Somatostatinanaloga,
  • Cancer,
  • Emploi en thérapeutique,
  • Chimiothérapie,
  • Somatostatine,
  • Krebs

  • Edition Notes

    Statemented., C. Scarpignato,...
    The Physical Object
    PaginationX-197 p.
    Number of Pages197
    ID Numbers
    Open LibraryOL27088402M
    ISBN 10380557035X
    ISBN 109783805570350
    OCLC/WorldCa468859709

    SOMATOSTATIN ANALOGUES FOR THE MANAGEMENT OF. NEUROENDOCRINE TUMOURS Effective Date: March, The recommendations contained in this guideline are a consensus of the Alberta Provincial Endocrine Tumour Team and are a synthesis of currently accepted approaches to management. Somatostatin Analogs and Interferon. The combination of SSAs and interferon (IFN) has been used in an effort to enhance the anti-proliferative effect of IFN therapy, to add the positive effect of SSAs on Cited by:

      Weckbecker G, Tolcsvai L, Stolz B, Pollak M, Bruns C: Somatostatin analog octreotide enhances the antineoplastic effects of tamoxifen and ovarietomy on 7,dimethylben-z(a)anthracene-induced rat mammary carcinomas. Cancer Cited by:   Heloisa P. Soares, MD: Somatostatin analogs have been around for a very long time. Initially, one of the first papers that was published was about the use of octreotide, short acting, in the.

    Buy Peptides in Oncology III: Somatostatin and LH-RH Analogues (Recent Results in Cancer Research Book ): Read Kindle Store Reviews - Peptides in Oncology III: Somatostatin and LH-RH Analogues (Recent Results in Cancer Research Book . of somatostatin analogues in this situation (see, e.g., NCCN, ). The guidelines stated that administration of somatostatin analogues has variable effects on blood glucose levels in insulinomas. The guidelines explained that about 50 % of insulinomas have somatostatin receptors, and that somatostatin.


Share this book
You might also like
Discoveries (Infatuations)

Discoveries (Infatuations)

Problems of trade in fishery products.

Problems of trade in fishery products.

English country pottery.

English country pottery.

Sales strategy and management

Sales strategy and management

Hell branded.

Hell branded.

S. Ephraims prose refutations of Mani, Marcion, and Bardaisan, of which the greater part has been transcribed from the palimpsest B. M. Add. 14623 and is now first published

S. Ephraims prose refutations of Mani, Marcion, and Bardaisan, of which the greater part has been transcribed from the palimpsest B. M. Add. 14623 and is now first published

We two

We two

The courageous Christians

The courageous Christians

Modelled portrait heads.

Modelled portrait heads.

Teaching Communication

Teaching Communication

Việt Nam, a long history

Việt Nam, a long history

Coltsville Study Act of 2002

Coltsville Study Act of 2002

Iceland frozen food holdings plc

Iceland frozen food holdings plc

Intertraffic

Intertraffic

Cartooning (The Head & Figure)

Cartooning (The Head & Figure)

The Tree in the Wood

The Tree in the Wood

Somatostatin analogs in cancer management by Carmelo Scarpignato Download PDF EPUB FB2

Somatostatin and analogues in the treatment of cancer. A review. This book represents a snapshot of the state of clinical application of somatostatin analogues in cancer in the late s. There is undoubted utility in the palliation of the effects of hypersecretion of peptide hormones but no real indication of any useful cytotoxic activity in most : S J Mather.

Reprint of: ChemotherapyVol. 47, Suppl. 2 Although cytotoxic chemotherapy is very effective in the management of certain neoplasms such as testicular cancer Somatostatin Analogs in Cancer Management (CHEMOTHERAPY. Somatostatin Analogs in Cancer Management; It may be common practice to publish book versions of journal supplements but this is the first such example to reach the desk of this reviewer (reprint of Chemotherapy supplement 2).

In this age of instant electronic information retrieval the idea of producing such a hard copy version seems rather retrogressive, but for frequent referral it is still easier and quicker to reach for a book Author: S J Mather. Download the eBook Somatostatin Analogs in Cancer Management in PDF or EPUB format and read it directly on your mobile phone, computer or any device.

This book represents a snapshot of the state of clinical application of somatostatin analogues in cancer in the late s. There is undoubted utility in the palliation of the effects of hypersecretion of peptide hormones but no real indication of any useful cytotoxic activity in most cancers.

Somatostatin Analogs in Cancer Management Editor C. Scarpignato, Parma/Nantes 17 figures, 1 in color, and 16 tables, IA A n/*rn Basel • Freiburg • Paris • London • New York •. Lamberts, S.W.J. Somatostatin Analogs in Cancer Management: Foreword. Chemotherapy, 47(SUPPL.

doi/Author: Steven Lamberts. Featuring chapters from specialists in endocrinology, physiology, pathology, and nuclear medicine, this book provides a multidisciplinary approach to a wide variety of issues concerning somatostatin and its analogues. The book: Provides the most up-to-date coverage of somatostatin analog.

Work is also in progress on applying somatostatin analogs labeled with appropriate radionuclides such as indium, iodine, rhenium, or 90 yttrium in cancer therapy. Radiolabeled somatostatin. The discovery of somatostatin (SST) and the synthesis of a variety of analogues constituted a major therapeutic advance in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours Cited by: Use of a somatostatin analog (SMS ) in the glucagonoma syndrome.

Surgery. Dec; (6)– Ahlman H, Ahlund L, Dahlström A, Nilsson O, Skolnik G, Tisell LE, Tylén U. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome.

Br J by: Somatostatin analogs in lung cancer. Although high SSTR expression has been reported in both small-cell lung cancer (SCLC) and non-SCLC, the results obtained with somatostatin analogs in various Cited by: What are somatostatin analogues.

Somatostatin analogues are drugs that stop your body from making too many hormones. Some neuroendocrine tumours (NETs) make large amounts of hormones that cause a group of symptoms called carcinoid syndrome. Somatostatin analogues are a possible treatment for people with carcinoid syndrome.

Somatostatin and Cancer R.J. Robbins The potential role of somatostatin (SRIF) in the diagnosis and treatment of nonendocrine human cancers is reviewed, There have been many reports of the tory activity of SRIF on normal and transformed cells in vitro, Many processes involved in malignant tumor growth depend on autocrine growth mechanisms, and somatostatin Cited by: The patient population with the highest risk of developing HOS is described, along with the rationale for using somatostatin analogs, such as lanreotide, to treat and prevent high output.

Conclusion: In patients with CRC and protective ileostomies after primary resection, HOS could be treated with somatostatin analogs Cited by: 1. The use of somatostatin analogues in combination therapy for D3 prostate cancer sustains the novel concept in cancer treatment in which therapies may target not only cancer cells, but also the Cited by: Somatostatin and its Analogs.

are aberrantly expressed in many cancer cells and tumor blood vessels, internalizing SST analogs is currently being used as drug-delivery vehicle for the. The somatostatin analogue is linked to the radionuclide via a specific chelator. This radio-analog complex binds to the membrane somatostatin receptor and is internalized.

Thus, radioactivity is Cited by: Somatostatin analogs have also been applied in the management of NET suffering patients in which, similarly to acromegalic individuals, an altered glucose tolerance has been documented (Cirillo Author: Fernando Cirillo.

Somatostatin is a peptide hormone that mediates its inhibitory effects through binding to specific cell surface, G-protein–coupled receptors, of which five distinct subtypes (sst 1 –sst 5) have been characterized. 16 – 18 Cells and tissues targeted by somatostatin .Somatostatin is an endogenous inhibitor of secretion and cell proliferation.

These features render somatosta-tin a logical candidate for the management of neuroen-docrine tumors that express somatostatin receptors. Synthetic somatostatin analogs (SSAs) have longer half-lives than somatostatin.Somatostatin analogs and radiopeptides in cancer therapy Article Literature Review in Biopolymers 66(3) January with Reads How we measure 'reads'.